跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 30,607 条关于
“TRUST-I”
全部
30,607
临床试验
22,727
药物
622
机构
360
资讯
6,898
2年前
Taletrectinib Shows Durable Responses in Advanced ROS1-Positive NSCLC
2年前
Taletrectinib Shows Promise in ROS1-Positive NSCLC: Nuvation Bio Announces Positive Phase 2 Data
5个月前
Controlling AI Hallucinations: Building Evidence-Based Trust in Clinical and Scientific Workflows
去年
Taletrectinib Approved in China for ROS1-Positive NSCLC, Showing Promise in TKI-Pretreated and Naive Patients
去年
Taletrectinib Shows Promise in ROS1-Positive NSCLC, Including TKI-Pretreated Patients
3个月前
Americans' Trust in CDC Plummets to 50% Amid Political Polarization, Harvard Poll Reveals
10天前
RCP Review Finds "Betrayal of Trust" in Prolonged Temozolomide Prescribing at Coventry NHS Trust
2个月前
Global Trust in Science Remains High Despite Political Polarization, Landmark 68-Country Survey Reveals
18天前
ACTO CEO Parth Khanna: AI Trust in Pharma Comes Down to 'Compliant Plus Capable'
昨天
FDA Approves Taletrectinib Label Update Showing 49.7-Month Median Duration of Response in ROS1+ NSCLC
第 1 页,共 690 页
上一页
下一页